Uses 　　　　　　6-Chloro-3-methyluracil  is intermediate of Alogliptin & Trelagliptin

Alogliptin tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see Clinical Studies (14)].Important Limitations of UseAlogliptin tablets are not indicated for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings.

Trelagliptin (Zafatek(®)) is an orally active dipeptidyl peptidase (DPP)-4 inhibitor developed by Takeda and approved in Japan for the treatment of type 2 diabetes mellitus (T2DM). Unlike other approved agents of its class, which are usually administered once daily, trelagliptin can be administered once weekly.

1.  what is its main application?

It is  intermediate of Alogliptin & Trelagliptin

2.  how many years we produced it, and what is its capactity

It produced since 2018。 And capacity is 50mt annually.

3. what is plant location and nearest port

It located in a chemical zone Fujian province., and nearest port is Xiamen port

4.  if doc. Support and audit available?

Yes, VQ and allied tech. package is available for serious client.  Audit could be accepted for clients having business more than 1 year.

5.  what other products are producing or plan to produce in this plant 

Advanced pharmaceutical intermediates，e.g. intermediats of Pramipexole，Rivastigmine，Ramatroban，ivacaftor，Olaparib etc.